Entrada Therapeutics (TRDA) Return on Equity [ROE] (2021 - 2026)
Entrada Therapeutics' Return on Equity [ROE] was -65.77% in Q2 2026, down 47.36 percentage points from -18.41% a year earlier and down 8.17 percentage points from the prior quarter.
Powered by 
Analysis
Entrada Therapeutics (TRDA) Return on Equity [ROE] (2021 - 2026) Analysis & Trends
For FY2025, Return on Equity [ROE] at Entrada Therapeutics came in at -39.13%, down 58.68 percentage points from FY2024.
- Return on Equity [ROE] shows a four-year change of +0.65 percentage points (FY2021 to FY2025).
- In earlier years, Return on Equity [ROE] was 19.55% in FY2024 (+22.47 pp), -2.92% in FY2023 (+34.09 pp), -37.01% in FY2022 (+2.76 pp) and -39.78% in FY2021.
- The Q2 2026 figure marks the lowest quarterly Return on Equity [ROE] in data going back to Q4 2021.
- Compared with a year earlier, Return on Equity [ROE] has declined for six straight quarters, with an average year-over-year change of -27.91 percentage points over the last eight quarters.
- The best year-over-year quarter for Return on Equity [ROE] over five years was Q2 2024 (a gain of 67.63 percentage points); the worst was Q1 2026 (a drop of 63.45 percentage points).
- Per Business Quant data, TRDA's Return on Equity [ROE] in the three quarters before Q2 2026 was -57.60% (Q1 2026), -44.46% (Q4 2025) and -28.75% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | Entrada Therapeutics | 205.54 Mn | -172.82 Mn | - | -75.08% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -75.08% |
| Jun 30, 2026 | -65.88% |
| Mar 31, 2026 | -57.65% |
| Dec 31, 2025 | -44.23% |
| Sep 30, 2025 | -28.83% |
| Jun 30, 2025 | -18.23% |
| Mar 31, 2025 | 6.02% |
| Dec 31, 2024 | 15.37% |
| Sep 30, 2024 | 13.24% |
| Jun 30, 2024 | 30.06% |
| Mar 31, 2024 | 9.33% |
| Dec 31, 2023 | -1.81% |
| Sep 30, 2023 | -8.61% |
| Jun 30, 2023 | -37.16% |
| Mar 31, 2023 | -35.61% |
| Dec 31, 2022 | -43.37% |
| Sep 30, 2022 | -37.27% |
| Jun 30, 2022 | -29.99% |
| Mar 31, 2022 | -22.91% |
| Dec 31, 2021 | -45.25% |
API Access
Entrada Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=TRDA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "TRDA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=TRDA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();